Search Ontology:
ChEBI

gadoterate meglumine

Term ID
CHEBI:73727
Synonyms
  • 1-deoxy-1-(methylazaniumyl)-D-glucitol [2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl-kappa(4)N(1),N(4),N(7),N(10))tetraacetato(4-)]gadolinate(1-)
  • [2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl-kappa(4)N(1),N(4),N(7),N(10))tetraacetato(3-)]gadolinium--1-deoxy-1-(methylamino)-D-glucitol (1/1)
  • Gadolinium-DOTA meglumine
  • Gd-DOTA meglumine
  • Meglumine gadopentate
  • Meglumine gadoterate
(all 6)
Definition
An organoammonium salt obtained by reaction of gadoteric acid with one equivalent of 1-deoxy-1-(methylamino)-D-glucitol (meglumine). It is used in magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues of patients ages 2 years and older, to detect and visualise areas with disruption of the blood brain barrier and/or abnormal vascularity of the central nervous system.
References
(all 21)
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from gadoterate meglumine
No data available
Phenotype where environments contain gadoterate meglumine
No data available
Phenotype modified by environments containing gadoterate meglumine
No data available
Phenotype affecting gadoterate meglumine
Human Disease Model